LevitasBio
San Francisco
About LevitasBio
Levitas is redefining cellular analytics with its novel platform of magnetic levitation technology. Their disruptive technology overcomes the current technological limitations of cellular analysis by providing label-free, simple, and universal methods of analysis. The company's platform, the LeviCell enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $72.8M
- Last round: Series Unknown (Mar 2024)
- Website: levitasbio.com
- Phone: 415-947-2470
Industries & Categories
Analytics, Biotechnology, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/levitasbio-59556 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.